Table 2 Clinical treatment between two groups
Characteristic | NO Live Birth | Live Birth | t/\({{\upchi }}^{2}\) | p |
|---|---|---|---|---|
Numbers of cycle | 876 | 504 | ||
Treatment Protocols | ||||
Prolonged GnRH-agonist | 729(83.22%) | 358(71.03%) | ||
GnRH-agonist | 113(12.9%) | 109(21.63%) | ||
GnRH-antagonist | 29(3.31%) | 28(5.56%) | ||
Mild Stimulation | 5(0.57%) | 9(1.79%) | 29.7399 | < 0.0001 |
Start Dose of Gonadotrophins(IU) | ||||
< 100 | 87(9.93%) | 50(9.92%) | ||
100 | 324(36.99%) | 180(35.71%) | ||
112.5 | 398(45.43%) | 203(40.28%) | ||
> 112.5 | 67(7.65%) | 71(14.09%) | 15.3588 | 0.0015 |
Total Dose of (IU)Gonadotrophins | 1947.13 ± 1007.42 | 1934.7 ± 1105.3 | 0.21 | 0.8356 |
Total days of Gonadotrophins | 12.95 ± 3.25 | 12.61 ± 3.27 | 1.87 | 0.0617 |
LH on HCG trigger day (mIU/mL) | 1.22 ± 1.18 | 1.43 ± 1.51 | 2.53 | 0.0116 |
P on HCG trigger day (ng/mL) | 0.6 ± 0.81 | 0.69 ± 0.77 | 0.64 | 0.5201 |
E2 on HCG trigger day (pg/mL) | 3253.91 ± 1845.03 | 3332.21 ± 1922.96 | 1.49 | 0.1397 |
Endometrial thickness on HCG trigger day (mm) | 10.69 ± 2.12 | 10.5 ± 2.49 | 1.46 | 0.1433 |
Oocytes Retrieved | ||||
1~10 | 150(17.12%) | 132(26.19%) | ||
11~15 | 258(29.45%) | 110(21.83%) | ||
16~20 | 243(27.74%) | 122(24.21%) | ||
> 20 | 225(25.68%) | 140(27.78%) | 21.8899 | < 0.0001 |
Insemination method | ||||
IVF | 736(84.02%) | 419(83.13%) | ||
ICSI | 103(11.76%) | 59(11.71%) | ||
IVF + ICSI | 37(4.22%) | 26(5.16%) | 0.6432 | 0.725 |
Embryos transferable | 4.81 ± 2.91 | 3.41 ± 2.69 | 8.84 | < 0.0001 |
Numbers of embryo transferred | 1.79 ± 0.4 | 1.78 ± 0.43 | 0.49 | 0.6252 |